Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel.
Given the worldwide burden of neglected tropical diseases, there is ongoing need to develop novel anthelmintic agents to strengthen the pipeline of drugs to combat these burdensome infections. Many diseases caused by parasitic flatworms are treated using the anthelmintic drug praziquantel (PZQ), emp...
Enregistré dans:
Auteurs principaux: | Evgeny G Chulkov, Emery Smith, Claudia M Rohr, Nawal A Yahya, Sang-Kyu Park, Louis Scampavia, Timothy P Spicer, Jonathan S Marchant |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/abaa115946af4e45b4a03469ea0cec2b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel
par: Evgeny G. Chulkov, et autres
Publié: (2021) -
A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity.
par: Taisaku Nogi, et autres
Publié: (2009) -
Schistosome infection in Senegal is associated with different spatial extents of risk and ecological drivers for Schistosoma haematobium and S. mansoni.
par: Isabel J Jones, et autres
Publié: (2021) -
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
par: Dimitrios K Matthaiou, et autres
Publié: (2008) -
Non-invasive sampling of schistosomes from humans requires correcting for family structure.
par: Michelle L Steinauer, et autres
Publié: (2013)